Source: Annual Congress 2001 - BAL / induced sputum / breath condensate in lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Marruchella, D. Corbellini, M. Parravicini, A. Merizzi, M. Tondini (Piacenza, Sondalo, Esine, Italy). The value of BAL in the assessment of pulmonary sarcoidosis in clinical practice: a retrospective analysis. Eur Respir J 2001; 16: Suppl. 31, 528

Member's Comments

No comment yet.

Related content which might interest you: Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Predictive value of fibrinogen/D-dimer ratio in patients with pulmonary embolism: a retrospective study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Usefulness of the asthma predictive index in clinical practice: A systematic review and clinical epidemiological analysis Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012 Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018 Year: 2019 Comparative evaluation of diagnosis methods in the patients with pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis Source: International Congress 2019 – Medical education Year: 2019 Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 The clinical and radiological spectrum of organizing pneumonia: retrospective analysis of 38 cases Source: Eur Respir J 2002; 20: Suppl. 38, 63s Year: 2002 The retrospective evaluation of pulmonary tuberculosis cases with DM Source: Eur Respir J 2004; 24: Suppl. 48, 421s Year: 2004 Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis Source: Eur Respir Rev, 30 (162) 210057; 10.1183/16000617.0057-2021 Year: 2021 Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Pulmonary sarcoidosis in children: a follow-up study Source: Eur Respir J 2001; 17: 628-635 Year: 2001 Paucibacillary pulmonary tuberculosis: Evaluation of clinical profile and study of radiological review Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010 Accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis. A study of 404 pulmonologists from 57 countries. Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 A systematic review and individual participant data meta-analysis of MMP-7 and outcomes in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice Source: Eur Respir J 2013; 42: 689-700 Year: 2013 Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019